Keyphrases
Prostate Cancer
75%
Radical Prostatectomy
41%
Prostate Cancer Risk
26%
Denmark
23%
Localized Prostate Cancer
17%
Androgen Deprivation Therapy
16%
Prostate Cancer Patients
16%
Prostate-specific Antigen
14%
Active Surveillance
13%
Clinically Significant Prostate Cancer
12%
Confidence Interval
11%
Prostate
11%
Prostate Cancer Screening
10%
Biochemical Recurrence
9%
Patients with Prostate Cancer
8%
Randomized Controlled Trial
8%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
8%
Castration-resistant Prostate Cancer
7%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
7%
Hazard Ratio
7%
Football
6%
Cumulative Incidence
6%
Curative Treatment
6%
Prostatic Artery Embolization
6%
Gleason Score
5%
Population-based Study
5%
Football Training
5%
Positive Surgical Margin
5%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
5%
Prostate-specific Antigen Testing
5%
Sweden
5%
Prostatic Cancer
5%
Benign Prostatic Hyperplasia
5%
Docetaxel
5%
Medicine and Dentistry
Prostate Cancer
100%
Prostatectomy
38%
Prostate Specific Antigen
18%
Biopsy
18%
Androgen Deprivation Therapy
14%
Randomized Controlled Trial
10%
Malignant Neoplasm
10%
Biochemical Recurrence
10%
Gleason Score
9%
Cancer Mortality
9%
Neoplasm
8%
Diagnosis
8%
Radiation Therapy
7%
Symptom
6%
Transrectal Ultrasonography
6%
Arterial Embolization
6%
Systematic Review
6%
Disease
6%
Castration Resistant Prostate Cancer
6%
Prostate Cancer Diagnosis
6%
Cancer Registry
6%
Cumulative Incidence
5%
Prostate Hypertrophy
5%
Quality of Life
5%
Diet and Cancer
5%
